Citation: B. Bodey et al., IMMUNOPHENOTYPICAL (IP) ANALYSIS OF PEDIATRIC PRIMARY BRAIN-TUMORS EMPLOYING AN EXTENSIVE LIBRARY OF MONOCLONAL-ANTIBODIES (MOABS), CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(1), 1998, pp. 10-10
Citation: B. Bodey et al., INTRATHYMIC NONLYMPHATIC HEMATOPOIESIS INDUCED BY AUTO-CRINE AND PARACRINE GROWTH-FACTOR SECRETION OF THE RETICULO-EPITHELIAL (RE) CELLULARMESHWORK, Experimental hematology, 26(8), 1998, pp. 331-331
Citation: B. Bodey et al., IMMUNOCYTOCHEMICAL DETECTION OF ENDOGLIN IS INDICATIVE OF ANGIOGENESIS IN MALIGNANT-MELANOMA, Anticancer research, 18(4A), 1998, pp. 2701-2710
Citation: B. Bodey et al., UP-REGULATION OF ENDOGLIN (CD105) EXPRESSION DURING CHILDHOOD BRAIN TUMOR-RELATED ANGIOGENESIS - ANTI-ANGIOGENIC THERAPY, Anticancer research, 18(3A), 1998, pp. 1485-1500
Citation: Se. Siegel, 100 YEARS OF HEROES - A HISTORY OF THE SOUTHWESTERN EXPOSITION AND LIVESTOCK SHOW - REYNOLDS,C, SCHEIN,MM, Journal of the West, 37(1), 1998, pp. 101-101
Authors:
HAYS DM
DOLGIN M
STEELE LL
PATENAUDE AF
HEWETT KD
RUYMANN F
RUCCIONE K
SALLAN S
SIEGEL SE
Citation: Dm. Hays et al., EDUCATIONAL-ACHIEVEMENT, EMPLOYMENT AND WORKPLACE EXPERIENCE OF ADULTSURVIVORS OF CHILDHOOD-CANCER, International journal of pediatric hematology/oncology, 4(4), 1997, pp. 327-337
Authors:
BODEY B
BODEY B
GROGER AM
LUCK JV
SIEGEL SE
TAYLOR CR
KAISER HE
Citation: B. Bodey et al., IMMUNOCYTOCHEMICAL DETECTION OF THE P170 MULTIDRUG-RESISTANCE (MDR) AND THE P53 TUMOR-SUPPRESSOR GENE PROTEINS IN HUMAN BREAST-CANCER CELLS- CLINICAL AND THERAPEUTIC SIGNIFICANCE, Anticancer research, 17(2B), 1997, pp. 1311-1318
Authors:
BODEY B
BODEY B
GROGER AM
LUCK JV
SIEGEL SE
TAYLOR CR
KAISER HE
Citation: B. Bodey et al., CLINICAL AND PROGNOSTIC-SIGNIFICANCE OF THE EXPRESSION OF THE C-ERBB-2 AND C-ERBB-3 ONCOPROTEINS IN PRIMARY AND METASTATIC MALIGNANT MELANOMAS AND BREAST CARCINOMAS, Anticancer research, 17(2B), 1997, pp. 1319-1330
Authors:
BODEY B
GROGER AM
BODEY B
SIEGEL SE
KAISER HE
Citation: B. Bodey et al., IMMUNOHISTOCHEMICAL DETECTION OF P53 PROTEIN EXPRESSION IN VARIOUS CHILDHOOD ASTROCYTOMA SUBTYPES - SIGNIFICANCE IN TUMOR PROGRESSION, Anticancer research, 17(2A), 1997, pp. 1187-1194
Authors:
BODEY B
BODEY B
GROGER AM
SIEGEL SE
KAISER HE
Citation: B. Bodey et al., CLINICAL AND PROGNOSTIC-SIGNIFICANCE OF KI-67 AND PROLIFERATING CELL NUCLEAR ANTIGEN EXPRESSION IN CHILDHOOD PRIMITIVE NEUROECTODERMAL BRAIN-TUMORS, Anticancer research, 17(1A), 1997, pp. 189-196
Authors:
BODEY B
GROGER AM
BODEY B
SIEGEL SE
KAISER HE
Citation: B. Bodey et al., IMMUNOHISTOCHEMICAL DETECTION OF P53 PROTEIN OVEREXPRESSION IN PRIMARY HUMAN OSTEOSARCOMAS, Anticancer research, 17(1A), 1997, pp. 493-498
Authors:
BODEY B
BODEY B
GROGER AM
SIEGEL SE
KAISER HE
Citation: B. Bodey et al., NM23 NUCLEOSIDE DIPHOSPHATE (NDP) KINASE EXPRESSION IN HUMAN-MALIGNANT MELANOMAS - SIGNIFICANCE AND IMPLICATIONS IN TUMOR BIOLOGY/, Anticancer research, 17(1A), 1997, pp. 505-511
Authors:
BODEY B
BODEY B
SIEGEL SE
LUCK JV
KAISER HE
Citation: B. Bodey et al., IMMUNOPHENOTYPIC CHARACTERIZATION OF HUMAN PRIMARY AND METASTATIC MELANOMA INFILTRATING LEUKOCYTES, Anticancer research, 16(6B), 1996, pp. 3439-3446
Authors:
NGUYEN QA
VILLABLANCA JG
SIEGEL SE
CROCKETT DM
Citation: Qa. Nguyen et al., ESTHESIONEUROBLASTOMA IN THE PEDIATRIC AGE-GROUP - THE ROLE OF CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION, International journal of pediatric otorhinolaryngology, 37(1), 1996, pp. 45-52
Citation: B. Bodey et al., IMMUNOPHENOTYPIC CHARACTERIZATION OF INFILTRATING POLYNUCLEAR AND MONONUCLEAR-CELLS IN CHILDHOOD BRAIN-TUMORS, Modern pathology, 8(3), 1995, pp. 333-338
Authors:
BALTHAZAR EJ
SIEGEL SE
MEGIBOW AJ
SCHOLES J
GORDON R
Citation: Ej. Balthazar et al., CT IN PATIENTS WITH SCIRRHOUS CARCINOMA OF THE GI TRACT - IMAGING FINDINGS AND VALUE FOR TUMOR-DETECTION AND STAGING, American journal of roentgenology, 165(4), 1995, pp. 839-845
Citation: B. Bodey et al., IMMUNOCYTOCHEMICAL OBSERVATION OF MULTIDRUG-RESISTANCE (MDR) P170 GLYCOPROTEIN EXPRESSION IN HUMAN OSTEOSARCOMA CELLS - THE CLINICAL-SIGNIFICANCE OF MDR PROTEIN OVEREXPRESSION, Anticancer research, 15(6B), 1995, pp. 2461-2468
Citation: J. Ninane et al., VARIATION IN THE USE OF ONDANSETRON AS AN ANTIEMETIC DRUG IN CHILDRENTREATED WITH CHEMOTHERAPY, Medical and pediatric oncology, 25(1), 1995, pp. 33-37
Citation: Se. Siegel, WHERE DO OBITUARY LISTINGS COME FROM - PUTTING THE MATTER TO REST, JAMA, the journal of the American Medical Association, 271(3), 1994, pp. 194-195
Authors:
ETTINGER LJ
GAYNON PS
KRAILO MD
RU N
BAUM ES
SIEGEL SE
HAMMOND GD
Citation: Lj. Ettinger et al., A PHASE-II STUDY OF CARBOPLATIN IN CHILDREN WITH RECURRENT OR PROGRESSIVE SOLID TUMORS - A REPORT FROM THE CHILDRENS CANCER GROUP, Cancer, 73(4), 1994, pp. 1297-1301